Curevo Vaccine

Curevo Vaccine

Biotechnology, -30th Drive Southeast Ste 260, Bothell, , 98021, Washington, 21540, United States, 11-50 Employees

curevovaccine.com

  • LinkedIn

phone no Phone Number: 12*********

Who is CUREVO VACCINE

Curevo will combine excellence in protein science and adjuvant technology to speed safe and highly effective vaccines from the bench through clinical development. Curevo will focus on vac...

Read More

map
  • 21540-30th Drive Southeast Ste 260, Bothell, Washington, 98021, United States Headquarters: 21540-30th Drive Southeast Ste 260, Bothell, Washington, 98021, United States
  • 2017 Date Founded: 2017
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies
  • George Simeon CEO:   George Simeon

industries-icon Industry: Biotechnology

SIC SIC Code: 8731

checked-icon Does something look wrong? Fix it. | View contact records from CUREVO VACCINE

Curevo Vaccine Org Chart and Mapping

Employees

Anna Wrem

Assoc. Director Program Mgmt.

David Miller

Senior Director of Strategic Communications

Svetlana Betz

Manager, Executive Office Operations

Tamra Madenwald

Associate Director Clinical Operations

Lisa Shelton

Director Clinical Development

Sein Pyo

Sr Cmc Operations Manager

Asq-Cqa Jennifer Ortiz Torres

Associate Director, Clinical Quality

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Curevo Vaccine

Answer: Curevo Vaccine's headquarters are located at -30th Drive Southeast Ste 260, Bothell, , 98021, Washington, 21540, United States

Answer: Curevo Vaccine's phone number is 12*********

Answer: Curevo Vaccine's official website is https://curevovaccine.com

Answer: Curevo Vaccine's revenue is $1 Million to $5 Million

Answer: Curevo Vaccine's SIC: 8731

Answer: Curevo Vaccine has 11-50 employees

Answer: Curevo Vaccine is in Biotechnology

Answer: Curevo Vaccine contact info: Phone number: 12********* Website: https://curevovaccine.com

Answer: Curevo will combine excellence in protein science and adjuvant technology to speed safe and highly effective vaccines from the bench through clinical development. Curevo will focus on vaccine-preventable illnesses that are common in both the Asian and US markets and for which current vaccine products are not available. Cuervo's goal is to rapidly advance innovative new vaccine candidates from the research laboratory to the clinic by joining forces with the South Korean Mogam Institute for Biomedical Research, GC Pharma, and the Infectious Disease Research Institute based in Seattle, Washington.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access